NHS Framework, North of England, Branded Medicines - Tranche A and Annual Tranche
Details
- Buyer
- NHS England
- Supplier(s)
26 suppliers
- Accord UK Ltd
- Allergan Limited
- Amgen Ltd
- Astra Zeneca UK Limited
- Bristol-Myers Squibb Pharmaceuticals Ltd
- Celltrion Healthcare United Kingdom Ltd
- Chugai Pharma UK Ltd
- Eli Lilly and Company Ltd
- Ferring Pharmaceutical
- GEDEON RICHTER (UK) LIMITED
- Ipsen
- Janssen Cilag Ltd
- Merck Serono Limited
- MERCK SHARP & DOHME (UK) LIMITED
- Merz
- Napp Pharmaceuticals Ltd
- Novartis Pharmaceutical UK Ltd
- Novo Nordisk Ltd
- Pfizer Liimted
- Pharmacosmos UK Ltd
- Roche Products Ltd
- Sandoz
- Teva UK Ltd
- Thornton and Ross
- UCB Pharma Ltd
- Vifor Pharma UK Ltd
- Value
- GBP 37
- Topic
- Pharmaceutical products
- Published
- 2 March 2021
- Source
- uk:find_a_tender
Tender description
Title: NHS Framework for the NHS North of England Region, Branded Medicines – Tranche A and Annual Tranche.Offer reference number: CM/PHR/20/5590The procurement comprises the following sub-tenders:CM/PHR/20/5590/01 - NHS Framework for the North of England Tranche A. Period of Framework: 1 March 2021 to 28 February 2023 with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 24 monthsCM/PHR/20/5590/02 - NHS Framework for the North of England Annual Tranche. Period of Framework: 1 March 2021 to 28 February 2022 with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 12 months Lot 1: Lot 1: North of England (NOFE) Tranche A CM/PHR/20/5590/01 - NHS Framework for the North of England Tranche A. Period of Framework: 1 March 2021 to 28 February 2023 with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 24 months. Additional information: Price is not the only award criterion and all criteria are stated only in the procurement documents. Lot 2: Lot 2: North of England (NOFE) Annual Tranche CM/PHR/20/5590/02 - NHS Framework for the North of England Annual Tranche. Period of Framework: 1 March 2021 to 28 February 2022 with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 12 months. Additional information: Price is not the only award criterion and all criteria are stated only in the procurement documents
Timeline
- Completed: Award date10 February 2021
- Completed: Award published2 March 2021Current notice
About the buyer
NHS England is a public sector buyer in United Kingdom publishing tenders and awards on Stotles. Explore their procurement activity and find more opportunities like this one.
Relevant CPV codes
- 33600000 · Pharmaceutical products
Decision makers
Connect with the people behind this procurement.
| Contact name | Job title | Phone number | Work email |
|---|---|---|---|
| Head of Procurement | +44 •••• •••••• | ••••••••@nhs-england.gov | |
| Commercial Director | +44 •••• •••••• | ••••••••@nhs-england.gov | |
| Procurement Manager | +44 •••• •••••• | ••••••••@nhs-england.gov | |
| Category Lead | +44 •••• •••••• | ••••••••@nhs-england.gov | |
| Senior Buyer | +44 •••• •••••• | ••••••••@nhs-england.gov | |
| Contracts Manager | +44 •••• •••••• | ••••••••@nhs-england.gov |
6 similar open tenders
See more open tenders related to NHS Framework, North of England, Branded Medicines - Tranche A and Annual Tranche.
- Open tender
IMP Manufacture, Labelling and Packaging DPS
- Open tender
CPH037 - Enhanced Services (Pharmacies)
- Open tender
Potassium iodide tablets 2024-2026
Related buyers
Buyers similar to NHS England.
- 455£2.1bn
- 367£249.3m
- 357£15.0bn
- 293£2.8bn
- 263£19.7bn
- 253£892.5m
- 246£509.3m
- 203£1.0bn
- 140£895.5m
- 115£59.6m
Win more public sector contracts
Track every UK and Ireland tender in one place — set up alerts, find decision-makers, and never miss an opportunity.
